<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>ICD improves survival in MADIT II</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">ICD improves survival in MADIT II</h1>
<div class="graphic"><div class="figure"><div class="ttl">ICD improves survival in MADIT II</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Kaplan-Meier estimates of the probability of survival in the MADIT II trial in 1232 patients who had a myocardial infarction more than 30 days prior to enrollment (and more than three months if bypass surgery was performed) and an LVEF â‰¤30 percent. The patients were randomly assigned to a prophylactic ICD or conventional medical therapy. The study was prematurely terminated after an average follow-up of 20 months because the ICD significantly reduced all-cause mortality (14.2 versus 19.8 percent for conventional therapy, hazard ratio 0.65, 95% CI 0.51-0.93). The survival benefit was largely due to a reduction in sudden death.</div><div class="graphic_footnotes">LVEF: left ventricular ejection fraction; ICD: implantable cardioverter-defibrillator.</div><div class="graphic_reference">Data from: Moss AJ, Zareba W, Hall WJ, et al. N Engl J Med 2002; 346:877.</div><div id="graphicVersion">Graphic 63529 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
